Ischemic preconditioning: Interruption of various disorders

Gersh, 2010, The epidemic of cardiovascular disease in the developing world: global implications, Eur Heart J, 31, 642, 10.1093/eurheartj/ehq030 Gasser, 1994, Experimental models and definitions of myocardial ischemia: a review, Int J Angiol, 3, 154, 10.1007/BF02014935 Kloner, 1993, Does reperfusion injury exist in humans?, J Am Coll Cardiol, 21, 537, 10.1016/0735-1097(93)90700-B Collard, 2001, Pathophysiology, clinical manifestation and prevention of ischemia reperfusion injury, Anesthesiology, 94, 1133, 10.1097/00000542-200106000-00030 Matsumura, 1998, Progression of myocardial necrosis during reperfusion of ischemic myocardium, Circulation, 97, 795, 10.1161/01.CIR.97.8.795 Frangogiannis, 2002, The inflammatory response in myocardial infarction, Cardiovasc Res, 53, 31, 10.1016/S0008-6363(01)00434-5 Zhao, 2003, Inhibition of myocardial injury by ischemic postconditioning during reperfusion comparison with ischemic preconditioning, Am J Physiol Heart Circ Physiol, 285, H579, 10.1152/ajpheart.01064.2002 Park, 1999, Mechanisms of myocardial reperfusion injury, Ann Thorac Surg, 68, 1905, 10.1016/S0003-4975(99)01073-5 Rosano, 2008, Cardiac metabolism in myocardial ischemia, Curr Pharm Des, 14, 2551, 10.2174/138161208786071317 Murry, 1986, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation, 74, 1124, 10.1161/01.CIR.74.5.1124 Tomai, 1999, Ischemic preconditioning in humans: models, mediators, clinical relevance, Circulation, 100, 559, 10.1161/01.CIR.100.5.559 Downey, 1997, Preconditioning: what it is and how it works, Dial Cardiovasc Med, 2, 179 Yellon, 2003, Preconditioning the myocardium: from cellular physiology to clinical cardiology, Physiol Res, 83, 1113 Kuzuya, 1993, Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia, Circ Res, 72, 1293, 10.1161/01.RES.72.6.1293 Marber, 1993, Cardiac stress protein elevation 24hours after brief ischemia or heat stress is associated with resistance to myocardial infarction, Circulation, 88, 1264, 10.1161/01.CIR.88.3.1264 Bolli, 1996, The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview, Basic Res Cardiol, 91, 57, 10.1007/BF00788866 Sisakiyan, 2008, Pathophysiology, clinical significance and possibilities of cardioprotection in myocardial stunning, hibernation and preconditioning, New Am Med J, 2, 28 Murphy, 2004, Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection, Circ Res, 94, 7, 10.1161/01.RES.0000108082.76667.F4 Liu, 1991, Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart, Circulation, 84, 350, 10.1161/01.CIR.84.1.350 Goto, 1995, Role of bradykinin in protection of ischemic preconditioning in rabbit hearts, Circ Res, 77, 611, 10.1161/01.RES.77.3.611 Cohen, 2007, Preconditioning mimetics bradykinin and DADLE activate PI3K through divergent pathways, J Mol Cell Cardiol, 42, 842, 10.1016/j.yjmcc.2007.01.004 Schultz, 1995, Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts, Am J Physiol, 268, H2157 Banerjee, 1993, Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism, Circ Res, 73, 656, 10.1161/01.RES.73.4.656 Yao, 1993, Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning in dogs, Circ Res, 73, 1193, 10.1161/01.RES.73.6.1193 Mocanu, 2002, PI3K and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning, J Mol Cell Cardiol, 34, 661, 10.1006/jmcc.2002.2006 Tyagi, 2002, Ischemic preconditioning of myocardium, Acta Pharmacol Sin, 23, 865 Jonassen, 2004, P70S6 kinase is a functional target of insulin activated Akt cell-survival signaling, Biochem Biophys Res Commun, 315, 160, 10.1016/j.bbrc.2004.01.029 Kis, 2003, Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase, J Mol Cell Cardiol, 35, 1063, 10.1016/S0022-2828(03)00208-6 Tong, 2000, Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C, Circ Res, 87, 309, 10.1161/01.RES.87.4.309 Tong, 2002, Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase–dependent pathway is cardioprotective, Circ Res, 90, 377, 10.1161/01.RES.0000012567.95445.55 Oldenburg, 2002, Acetylcholine leads to free radical production dependent on KATP channels, Gi proteins, phosphatidylinositol 3-kinase and tyrosine kinase, Cardiovasc Res, 55, 544, 10.1016/S0008-6363(02)00332-2 Garlid, 1997, Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive KATP channels: possible mechanism of cardioprotection, Circ Res, 81, 1072, 10.1161/01.RES.81.6.1072 Mitchell, 1995, Preconditioning of isolated rat heart is mediated by protein kinase C, Circ Res, 76, 73, 10.1161/01.RES.76.1.73 Tong, 2004, G protein coupled receptor internalization signaling is required for cardioprotection in ischaemic preconditioning, Circ Physiol, 283, H61 Sato, 1998, Modulation of mitochondrial ATP dependent K+ channels by protein kinase C, Circ Res, 83, 110, 10.1161/01.RES.83.1.110 Dreixler, 2008, Protein kinase C subtypes and retinal ischemic preconditioning, Exp Eye Res, 87, 300, 10.1016/j.exer.2008.05.015 Downey, 2006, Reducing infarct size in the setting of acute myocardial infarction, Prog Cardiovasc Dis, 48, 363, 10.1016/j.pcad.2006.02.005 Penna, 2009, Cardioprotection: a radical view. Free radicals in pre and postconditioning, Biochim Biophys Acta, 1787, 781, 10.1016/j.bbabio.2009.02.008 Baines, 1997, Oxygen radicals released during ischaemic preconditioning contribute to cardioprotection in the rabbit myocardium, J Mol Cell Cardiol, 29, 207, 10.1006/jmcc.1996.0265 Vanden Hoek, 1998, Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes, J Biol Chem, 273, 18092, 10.1074/jbc.273.29.18092 Baines, 2003, Protein kinase C interacts with and inhibits the permeability transition pore in cardiac mitochondria, Circ Res, 92, 873, 10.1161/01.RES.0000069215.36389.8D Zoratti, 2009, Novel channels of the inner mitochondrial membrane, Biochim Biophys Acta, 1787, 351, 10.1016/j.bbabio.2008.11.015 Kroemer, 1998, The mitochondrial death/life regulator in apoptosis and necrosis, Annu Rev Physiol, 60, 619, 10.1146/annurev.physiol.60.1.619 Hausenloy, 2004, Preconditioning protects by inhibiting the mitochondrial permeability transition, Am J Physiol Heart Circ Physiol, 287, H841, 10.1152/ajpheart.00678.2003 Hausenloy, 2007, Preconditioning and postconditioning: united at reperfusion, Pharmacol Ther, 116, 173, 10.1016/j.pharmthera.2007.06.005 Juhaszova, 2004, Glycogen synthase kinase-3β mediates convergence of protection signalling to inhibit the mitochondrial permeability transition pore, J Clin Invest, 113, 1535, 10.1172/JCI19906 Miura, 2009, GSK-3β, a therapeutic target for cardiomyocyte protection, Circ J, 73, 1184, 10.1253/circj.CJ-09-0284 Javador, 2003, Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart, J Physiol, 549, 513, 10.1113/jphysiol.2003.034231 Tsang, 2004, Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3- kinase-Akt pathway, Circ Res, 95, 230, 10.1161/01.RES.0000138303.76488.fe Gomez, 2008, Inhibition of GSK3β by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion, Circulation, 117, 2761, 10.1161/CIRCULATIONAHA.107.755066 Ferdinandy, 1998, Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon?, Trends Pharmacol Sci, 19, 223, 10.1016/S0165-6147(98)01212-7 Ferdinandy, 2003, Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemia, Br J Pharmacol, 138, 283, 10.1038/sj.bjp.0705097 Mahgoub, 1998, Diabetes mellitus and cardiac function, Mol Cell Biochem, 180, 59, 10.1023/A:1006834922035 Kersten, 1995, Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycaemic dogs, Am J Physiol Heart Circ Physiol, 268, H1667, 10.1152/ajpheart.1995.268.4.H1667 Giugliano, 1997, Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia, Circulation, 95, 1783, 10.1161/01.CIR.95.7.1783 Yang, 2009, Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion, J Thorac Cardiovasc Surg, 137, 723, 10.1016/j.jtcvs.2008.08.056 Jaffe, 1984, Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus, Am Heart J, 108, 31, 10.1016/0002-8703(84)90541-6 Tani, 1988, Hearts from diabetic rats are more resistant to in vitro ischemia: possible role of altered Ca2+ metabolism, Circ Res, 62, 931, 10.1161/01.RES.62.5.931 Gamble, 1994, Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats, Biochem Biophys Acta, 1225, 191 Herlitz, 1996, Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting, Diabetes Care, 19, 698, 10.2337/diacare.19.7.698 Abel, 2004, Insulin signalling in heart muscle: lessons from genetically engineered mouse models, Curr Hypertens Rep, 6, 416, 10.1007/s11906-004-0034-4 Abel, 2005, Myocardial insulin resistance and cardiac complications of diabetes, Curr Drug Targets Immune Endocr Metabol Disord, 5, 219, 10.2174/1568008054064869 Fein, 1994, Diabetic cardiomyopathy. Cardiovascular stress in disease states: is preconditioning a healthy heart phenomenon?, Drugs Ther, 8, 65 Ravingerova, 2000, Acute diabetes modulates response to ischemia in isolated rat heart, Mol Cell Biochem, 210, 143, 10.1023/A:1007129708262 Greden, 2005, Altered expression of adenosine receptors in heart of diabetic rat, J Physiol Pharmacol, 56, 587 Kersten, 2001, Diabetes and hyperglycemia impair activation of mitochondrial KATP channel, Am J Physiol Heart Circ Physiol, 280, H1744, 10.1152/ajpheart.2001.280.4.H1744 Liu, 1993, Streptozotocin induced non-insulin-dependent diabetes protects the heart from infarction, Circulation, 88, 1273, 10.1161/01.CIR.88.3.1273 Kusama, 1992, Diabetes and susceptibility to reperfusion-induced ventricular arrhythmias, J Mol Cell Cardiol, 24, 411, 10.1016/0022-2828(92)93195-P Otani, 2008, Ischemic preconditioning: from molecular mechanism to therapeutic opportunities, Antioxid Redox Signal, 10, 207, 10.1089/ars.2007.1679 Wohaieb, 1987, Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effects of insulin treatment, Diabetes, 36, 1014, 10.2337/diab.36.9.1014 Matejikova, 2008, The effect of antioxidant treatment and nos inhibition on the incidence of ischemia-induced arrhythmias in the diabetic rat heart, Physiol Res, 57, S55, 10.33549/physiolres.931552 Ganguly, 1983, Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy, Am J Physiol, 244, E528 Allo, 1991, Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation, Am J Physiol, 260, C1165, 10.1152/ajpcell.1991.260.6.C1165 Atkins, 1985, β-adrenergic receptors, adenylate cyclise activity and cardiac dysfunction in the diabetic rats, J Cardiovasc Pharmacol, 7, 66, 10.1097/00005344-198501000-00011 Schaffer, 1991, Cardiomyopathy associated with noninsulin-dependent diabetes, Mol Cell Biochem, 107, 1, 10.1007/BF02424571 Moon, 1999, Protein kinase C inhibitors abolish the increased resistance of the diabetic rat heart to ischemia-reperfusion injury, Jpn J Physiol, 49, 409, 10.2170/jjphysiol.49.409 Lu, 2001, Role of calcitonin gene-related peptide in ischemic preconditioning in diabetic rat hearts, Clin Exp Pharmacol Physiol, 28, 392, 10.1046/j.1440-1681.2001.03467.x Mori, 2006, Cardioprotective effect of ischemic preconditioning on ischemia/reperfusion injury in spontaneously type 2 diabetic rat heart, Jikeikai Med J, 53, 69 Ghosh, 2001, Failure to precondition pathological human myocardium, J Am Coll Cardiol, 37, 711, 10.1016/S0735-1097(00)01161-X Paulson, 1997, The diabetic heart is more sensitive to ischemic injury, Cardiovasc Res, 34, 104, 10.1016/S0008-6363(97)00018-7 Tatsumi, 1998, Energy metabolism after ischemic preconditioning in streptozotocin-induced diabetic rat heart, JACC, 31, 707, 10.1016/S0735-1097(97)00556-1 Ravingerová, 2000, Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart, Physiol Res, 49, 607 Charan, 2016, Role of atrial natriuretic peptide in ischemic preconditioning induced cardioprotection in diabetic rat heart, J Surg Res, 201, 272, 10.1016/j.jss.2015.10.045 Tosaki, 1996, The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts, Cardiovasc Res, 31, 526, 10.1016/S0008-6363(95)00217-0 Smith, 1996, ATP-sensitive potassium channels are altered in ventricular myocytes from diabetic rats, Mol Cell Biochem, 158, 43, 10.1007/BF00225881 Hassouna, 2006, Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium, Cardiovasc Res, 69, 450, 10.1016/j.cardiores.2005.11.004 Baines, 1997, Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium, J Mol Cell Cardiol, 29, 207, 10.1006/jmcc.1996.0265 Miura, 1997, Diabetes mellitus impairs ATP-sensitive potassium channel function of human coronary arterioles, Circulation, 96, 1 Magyar, 1992, Action potential and potassium currents in rat ventricular muscle during experimental diabetes, J Mol Cell Cardiol, 24, 841, 10.1016/0022-2828(92)91098-P Ajmani, 2011, Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart, BMC Cardiovasc Disord, 11, 43, 10.1186/1471-2261-11-43 Engler, 1996, Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease: time for reconsideration, Circulation, 94, 2297, 10.1161/01.CIR.94.9.2297 Cleveland, 1997, Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium: two paradoxes revisited, Circulation, 96, 29, 10.1161/01.CIR.96.1.29 Ashcroft, 1992, The sulfonylurea receptor, Biochim Biophys Acta, 1175, 45, 10.1016/0167-4889(92)90008-Y Terzic, 1995, Cardiac ATP-sensitive K channels: Regulation by intracellular nucleotides and K channel-opening drugs, Am J Physiol, 269, C525, 10.1152/ajpcell.1995.269.3.C525 Tsang, 2005, Preconditioning the diabetic heart: the importance of Akt phosphorylation, Diabetes, 54, 2360, 10.2337/diabetes.54.8.2360 Chen, 2005, Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type1 diabetic rats, Acta Pharmacol Sin, 26, 806, 10.1111/j.1745-7254.2005.00113.x Ting, 2011, Study on tolerance to ischemia-reperfusion injury and protection of ischemic preconditioning of type diabetes rat heart, Biomed Aging Pathol, 1, 56, 10.1016/j.biomag.2010.09.004 Ghaboura, 2011, Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signalling, Basic Res Cardiol, 106, 147, 10.1007/s00395-010-0130-3 Juhaszova, 2004, Glycogen synthase kinase-3β mediates convergence of protection signalling to inhibit the mitochondrial permeability transition pore, J Clin Invest, 113, 1535, 10.1172/JCI19906 Wang, 2009, Inactivation of GSK-3β by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling, Diabetes, 58, 1391, 10.2337/db08-1697 Yadav, 2010, Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart, Mol Cell Biochem, 343, 75, 10.1007/s11010-010-0500-z Goldstein, 1973, Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction, J Clin Invest, 52, 1533, 10.1172/JCI107331 Tilton, 1987, Increased ischemia–reperfusion injury to the heart associated with short-term, diet-induced hypercholesterolemia in rabbits, Circ Res, 60, 551, 10.1161/01.RES.60.4.551 Golino, 1987, The effect of acute hypercholesterolaemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion–reperfusion, Circulation, 75, 292, 10.1161/01.CIR.75.1.292 Girod, 1999, Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice, Arterioscler Thromb Vasc Biol, 19, 2776, 10.1161/01.ATV.19.11.2776 Le, 1995, Increased resistance to ischaemic injury in the isolated perfused atherosclerotic heart of the cholesterol-fed rabbit, Cardiovasc Res, 30, 689, 10.1016/S0008-6363(95)00076-3 Kyriakides, 2002, Hyperlipidemia prevents the expected reduction of myocardial ischemia on repeated balloon inflations during angioplasty, Chest, 121, 1211, 10.1378/chest.121.4.1211 Szilvassy, 1995, The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolemia, J Mol Cell Cardiol, 27, 2559, 10.1006/jmcc.1995.0043 Ferdinandy, 1997, Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet, J Mol Cell Cardiol, 29, 3321, 10.1006/jmcc.1997.0557 Ungi, 2005, Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty, Chest, 128, 1623, 10.1378/chest.128.3.1623 Szekeres, 1997, Delayed cardiac protection against harmful consequences of stress can be induced in experimental atherosclerosis in rabbits, J Mol Cell Cardiol, 29, 1977, 10.1006/jmcc.1997.0418 Tang, 2005, Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits, Circulation, 112, 2149, 10.1161/CIRCULATIONAHA.105.566190 Csont, 2007, Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice, Cardiovasc Res, 76, 100, 10.1016/j.cardiores.2007.06.006 Lefer, 1993, Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium, Arterioscler Thromb, 13, 771, 10.1161/01.ATV.13.6.771 Deliconstantinos, 1995, Modulation of particulate nitric oxide synthase activity and peroxynitrite synthesis in cholesterol enriched endothelial cell membranes, Biochem Pharmacol, 49, 1589, 10.1016/0006-2952(95)00094-G White, 1994, Superoxide and peroxynitrite in atherosclerosis, Proc Natl Acad Sci USA, 91, 1044, 10.1073/pnas.91.3.1044 Szilvássy, 2001, Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine, J Vasc Res, 38, 39, 10.1159/000051028 Onody, 2003, Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts, Cardiovasc Res, 58, 663, 10.1016/S0008-6363(03)00330-4 Okamoto, 2001, Activation of matrix metalloproteinases by peroxynitrite-induced protein S glutathiolation via disulfide S-oxide formation, J Biol Chem, 276, 29596, 10.1074/jbc.M102417200 Wang, 2002, Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2, Cardiovasc Res, 53, 165, 10.1016/S0008-6363(01)00445-X Giricz, 2006, Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition, J Pharmacol Exp Ther, 316, 154, 10.1124/jpet.105.091140 Hao, 2004, Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway, Circ Res, 94, 68, 10.1161/01.RES.0000109413.57726.91 Cheung, 2000, Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart, Circulation, 101, 1833, 10.1161/01.CIR.101.15.1833 Lalu, 2005, Ischaemia–reperfusion injury activates matrix metalloproteinases in the human heart, Eur Heart J, 26, 27, 10.1093/eurheartj/ehi007 Görbe, 2011, Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43, Am J Physiol Heart Circ Physiol, 300, H1907, 10.1152/ajpheart.01242.2010 Genda, 2002, KATP channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia, J Am Coll Cardiol, 40, 1339, 10.1016/S0735-1097(02)02156-3 Laufs, 1998, Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors, Circulation, 97, 1129, 10.1161/01.CIR.97.12.1129 Kureishi, 2000, The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals, Nat Med, 6, 1004, 10.1038/79510 Ledoux, 2002, Lovastatin enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases, Circ Res, 90, 420, 10.1161/hh0402.105668 Barrett-Connor, 1997, Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture, Circulation, 95, 252, 10.1161/01.CIR.95.1.252 Sullivan, 1998, Postmenopausal estrogen use and coronary atherosclerosis, Ann Intern Med, 108, 358, 10.7326/0003-4819-108-3-358 Grodstein, 1995, The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women, Prog Cardiovasc Dis, 38, 199, 10.1016/S0033-0620(95)80012-3 Delyani, 1996, Protection from a myocardial reperfusion injury by acute administration of 17β-estradiol, J Mol Cell Cardiol, 28, 1001, 10.1006/jmcc.1996.0093 Beer, 2002, Susceptibility to cardiac ischemia/reperfusion injury is modulated by chronic estrogen status, J Cardiovasc Pharmacol, 40, 420, 10.1097/00005344-200209000-00011 Barrett-Connor, 1999, Hormones and heart disease in women: heart and estrogen/progestin replacement study in perspective, J Clin Endocrinol Metab, 84, 1848, 10.1210/jcem.84.6.5667 Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Ranki, 2001, Gender-specific difference in cardiac ATP-sensitive K+ channels, J Am Coll Cardiol, 38, 906, 10.1016/S0735-1097(01)01428-0 Bae, 2005, Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts and protein kinase C signalling, J Pharmacol Exp Ther, 315, 1125, 10.1124/jpet.105.090803 Kapadia, 1995, Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration, J Clin Invest, 96, 1042, 10.1172/JCI118090 Hirschl, 1996, Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction, Eur Heart J, 17, 1852, 10.1093/oxfordjournals.eurheartj.a014803 Liao, 2002, Estrogen attenuates tumor necrosis factor-alpha expression to provide ischemic neuroprotection in female rats, Neurosci Lett, 330, 159, 10.1016/S0304-3940(02)00754-1 Machikas, 2012, Increased mitochondrial permeability transition pore opening dominates ischemia–reperfusion injury in the aged female rat heart, Circ Res, 111, A342, 10.1161/res.111.suppl_1.A342 Shinmura, 2008, Loss of ischaemic preconditioning in ovariectomized rat hearts: Possible involvement of impaired protein kinase C€ phosphorylation, Cardiovasc Res, 79, 387, 10.1093/cvr/cvn086 Goyal, 2015, Abrogate cardioprotective effect of ischemic preconditioning in ovariectomized rat heart, Hum Exp Toxicol, 35, 644, 10.1177/0960327115597980 Wang, 2002, Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts, Am J Physiol Heart Circ Physiol, 282, H2309, 10.1152/ajpheart.00772.2001 Stampfer, 1991, Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses’ health study, N Engl J Med, 325, 756, 10.1056/NEJM199109123251102 Grady, 1992, Hormone therapy to prevent disease and prolong life in a postmenopausal women, Ann Intern Med, 117, 1016, 10.7326/0003-4819-117-12-1016 Best, 1998, The effect of estrogen a replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women, Ann Intern Med, 128, 285, 10.7326/0003-4819-128-4-199802150-00006 Levin, 2005, Integration of the extranuclear and nuclear actions of estrogen, Mol Endocrinol, 19, 1951, 10.1210/me.2004-0390 Hishikawa, 1995, Up regulation of nitric oxide synthase by estradiol in human aortic endothelial cells, FEBS Lett, 360, 291, 10.1016/0014-5793(95)00124-R Michel, 1997, Reciprocol regulation of endothelial nitric oxide synthatase by Ca2+ calmodulin and caveolin, J Biol Chem, 272, 15583, 10.1074/jbc.272.25.15583 Gavin, 2009, Vascular endothelial estrogen receptor α is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women, J Clin Endocrinol Metab, 94, 3513, 10.1210/jc.2009-0278 Chen, 1999, Estrogen receptor mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen, J Clin Invest, 103, 401, 10.1172/JCI5347 Simoncini, 2000, Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase, Nature, 407, 538, 10.1038/35035131 Hisamoto, 2001, Estrogen induces the Akt dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells, J Biol Chem, 276, 3459, 10.1074/jbc.M005036200 Haynes, 2000, Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells, Circ Res, 87, 677, 10.1161/01.RES.87.8.677 Camper-Kirby, 2001, Myocardial Akt activation and gender: increased nuclear activity in females versus males, Circ Res, 88, 1020, 10.1161/hh1001.090858 Fulton, 1999, Regulation of endothelium-derived nitric oxide production by the protein kinase Akt, Nature, 399, 597, 10.1038/21218 Dimmeler, 1999, Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, 399, 601, 10.1038/21224 McCabe, 2000, Enhanced electron flux and reduced calmodulin dissociation may explain “calcium-independent” eNOS activation by phosphorylation, J Biol Chem, 275, 6123, 10.1074/jbc.275.9.6123 Hale, 1996, Beta-estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion, Am Heart J, 132, 258, 10.1016/S0002-8703(96)90419-6 Kolodgie, 1997, Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat, J Mol Cell Cardiol, 29, 2403, 10.1006/jmcc.1997.0476 Fraser, 1999, Enhancement of post-ischemic myocardial function by chronic 17β-estradiol treatment: role of alterations in glucose metabolism, J Mol Cell Cardiol, 31, 1539, 10.1006/jmcc.1999.0986 Xu, 2006, Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-α, Cardiovasc Res, 69, 836, 10.1016/j.cardiores.2005.11.031 Montalcini, 2007, Endogenous testosterone and endothelial function in postmenopausal women, Coron Artery Dis, 1, 9, 10.1097/01.mca.0000236290.79306.d1 Liu, 2011, Testosterone enhances estradiols cardioprotection in ovariectomized rats, J Endocrinal, 11, 61, 10.1530/JOE-11-0181